𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Challenges to treatment: the price-infrastructure trap and access to HIV/AIDS drugs

✍ Scribed by Kenneth C. Shadlen

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
98 KB
Volume
16
Category
Article
ISSN
0954-1748

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The paper draws attention to broad issues in international political economy that affect responses to the HIV/AIDS epidemic in the developing world. I argue that stable access to affordable medicines is essential for developing countries to tackle HIV/AIDS epidemics. Developing countries must overcome the ‘price–infrastructure trap’, where high prices reduce the feasibility of scaling‐up treatment programmes, reduced feasibility of treatment decreases the incentives to invest in public health infrastructure, and poor public health infrastructure makes even limited treatment programs less effective than they could otherwise be. I examine four mechanisms for increasing developing countries' access to affordable drugs. I consider the political economy obstacles to scaling up treatment based on each of these mechanisms, with particular attention paid to the impediments posed by the new global regime on intellectual property rights. I show how each mechanism remains inadequate for realizing the central objective, that of achieving sufficient stability of supply so to stimulate domestic mobilization of resources and thereby escape from the price‐infrastructure trap. Copyright © 2004 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Globalization of intellectual property r
Globalization of intellectual property rights: Implications of the TRIPs agreement for access to HIV/AIDS drugs in Africa
✍ John Agada; John Gathegi; Johannes Britz; Peter Lor 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 62 KB

## Abstract During the past few decades, western countries have pushed for strengthening intellectual property (IP) rights, as well as enforcing them uniformly across the globe. This push came to a climax when the IP was removed from the World Intellectual Property Organization (WIPO) to become a t

A Markov model for HIV disease progressi
A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: Application to AIDS prediction in England and Wales
✍ Odd O. Aalen; Vernon T. Farewell; Daniela de Angelis; Nicholas E. Day; O. Nöel G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 2 views

Back-calculation is a widely used method to estimate HIV incidence rates, and is commonly based on times of AIDS diagnosis. Following up earlier work, we extend this method to also incorporate knowledge of times of HIV diagnosis (first positive test). This is achieved through the use of a Markov mod

Resistance to antiretroviral drugs in ne
Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa
✍ R. Parboosing; A. Naidoo; M. Gordon; M. Taylor; V. Vella 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract In 2004, KwaZulu‐Natal initiated one of the world's largest HIV/AIDS treatment programs. Studies in South Africa have shown that patients on antiretroviral therapy (ART) develop rapidly and transmit drug resistant mutations. Since resistance testing is not widely available in Kwazulu‐Na

Drug resistance mutations and newly reco
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients
✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an

The Production of oil of American Wormse
The Production of oil of American Wormseed, U. S. P., in Illinois**This investigation was undertaken because the supply of wormseed oil has been for several years vcry inadequate to the demand, and this condition has prevented extensive use of the oil in the treatment of domestic animals—a field in which it is much needed. Owing to the low individual value of such animals as hogs, for example, it is not economical to treat them with a drug of such high price as wormseed oil. This paper is a report of the first year’s work in producing this oil at the Experiment Station of the Moorman Mfg. Co., Quincy, Ill. It is planned to continue the work on a much larger scale, covering every phase of the problem. Anyone wishing to produce the oil can obtain the full cooperation of this company on request.
✍ Konantz, W.A. 📂 Article 📅 1924 🏛 Elsevier ⚖ 408 KB 👁 2 views